Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
US Army
Boehringer Ingelheim
Queensland Health
Express Scripts
QuintilesIMS

Generated: September 22, 2019

DrugPatentWatch Database Preview

Patent: 10,273,252

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,273,252
Title:Substituted dihydropyrrolopyrazole derivative
Abstract: The present invention provides a compound represented by the general formula (Ia) or a pharmacologically acceptable salt thereof. In the general formula (Ia), two R moieties each independently represent a C.sub.1-3 alkyl group or the like; and R.sup.1, R.sup.2 and R.sup.3 each independently represent an optionally substituted linear or branched C.sub.1-4 alkyl group. ##STR00001##
Inventor(s): Iwase; Noriaki (Ube, JP), Aga; Yasuhiro (Ube, JP), Ushiyama; Shigeru (Ube, JP), Kono; Shigeyuki (Ube, JP), Sunamoto; Hidetoshi (Ube, JP), Matsushita; Takashi (Ube, JP), Ogi; Sayaka (Ube, JP), Umezaki; Satoshi (Ube, JP), Kojima; Masahiro (Ube, JP), Onuma; Kazuhiro (Ube, JP), Shiraishi; Yusuke (Ube, JP), Okudo; Makoto (Ube, JP), Kimura; Tomio (Tokyo, JP)
Assignee: UBE INDUSTRIES, LTD. (Yamaguchi, JP)
Application Number:15/736,677
Patent Claims:see list of patent claims

Details for Patent 10,273,252

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck ELSPAR asparaginase VIAL 101063 001 1978-01-10   Try a Free Trial UBE INDUSTRIES, LTD. (Yamaguchi, JP) 2036-04-28 RX search
Bayer Healthcare Pharms BETASERON interferon beta-1b VIAL; SUBCUTANEOUS 103471 001 1993-07-23   Try a Free Trial UBE INDUSTRIES, LTD. (Yamaguchi, JP) 2036-04-28 RX Orphan search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17   Try a Free Trial UBE INDUSTRIES, LTD. (Yamaguchi, JP) 2036-04-28 RX search
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26   Try a Free Trial UBE INDUSTRIES, LTD. (Yamaguchi, JP) 2036-04-28 RX search
Novartis SIMULECT basiliximab VIAL; SINGLE-USE 103764 001 1998-05-12   Try a Free Trial UBE INDUSTRIES, LTD. (Yamaguchi, JP) 2036-04-28 RX search
Novartis SIMULECT basiliximab VIAL; SINGLE-USE 103764 002 1998-05-12   Try a Free Trial UBE INDUSTRIES, LTD. (Yamaguchi, JP) 2036-04-28 RX search
Eisai Inc ONTAK denileukin diftitox VIAL 103767 001 1999-02-05   Try a Free Trial UBE INDUSTRIES, LTD. (Yamaguchi, JP) 2036-04-28 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Mallinckrodt
Moodys
McKinsey
Cantor Fitzgerald
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.